Related references
Note: Only part of the references are listed.An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma
David J. Andorsky et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Anas Younes et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation
Rashmi Kanagal-Shamanna et al.
CANCER (2019)
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
David Ghez et al.
BLOOD (2018)
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma
John M. Burke et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis
Anthony R. Mato et al.
HAEMATOLOGICA (2018)
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
James D. Phelan et al.
NATURE (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome
Liron David et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis
Anthony R. Mato et al.
HAEMATOLOGICA (2018)
Phase 2 CAPTIVATE results of ibrutinib (ibr) plus venetoclax (ven) in first-line chronic lymphocytic leukemia (CLL).
William G. Wierda et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
Nancy L. Bartlett et al.
BLOOD (2018)
Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease
Agnieszka Malecka et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma
Keiichiro Hattori et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
Yanwen Jiang et al.
CANCER DISCOVERY (2017)
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition
Gabriele Varano et al.
NATURE (2017)
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
Claudia Minici et al.
NATURE COMMUNICATIONS (2017)
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
Dan A. Landau et al.
NATURE COMMUNICATIONS (2017)
The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma
Jiyuan Zhang et al.
CANCER DISCOVERY (2017)
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Christian Grommes et al.
CANCER DISCOVERY (2017)
PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma
Georgios N. Pongas et al.
ONCOTARGET (2017)
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
Ondrej Havranek et al.
BLOOD (2017)
Acquired mutations associated with ibrutinib resistance in Waldenstrom macroglobulinemia
Lian Xu et al.
BLOOD (2017)
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group
P-E Heudel et al.
BRITISH JOURNAL OF CANCER (2017)
Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT
Juliane Paul et al.
CANCER CELL (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
T. Nakamura et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
Genomic characterization of primary central nervous system lymphoma
Kazutaka Fukumura et al.
ACTA NEUROPATHOLOGICA (2016)
Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL
Paul M. Barr et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
Agnieszka Malecka et al.
HAEMATOLOGICA (2016)
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
Jingjing Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
An improved smaller biotin ligase for BioID proximity labeling
Dae In Kim et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma
Lixin Rui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Conformational dynamics of cancer-associated MyD88-TIR domain mutant L252P (L265P) allosterically tilts the landscape toward homo-dimerization
Chendi Zhan et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
Florian Scherer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
Agnieszka Malecka et al.
HAEMATOLOGICA (2016)
MYD88 (L265P) Somatic Mutation in Marginal Zone B-cell Lymphoma
Azahara Martinez-Lopez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
Esteban Braggio et al.
CLINICAL CANCER RESEARCH (2015)
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
David W. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
Priscilla N. Kelly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations
So Yamada et al.
LEUKEMIA & LYMPHOMA (2015)
Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
Christopher M. Tipton et al.
NATURE IMMUNOLOGY (2015)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis
Jiyuan Zhang et al.
NATURE MEDICINE (2015)
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
Ana Ortega-Molina et al.
NATURE MEDICINE (2015)
The B-cell antigen receptor integrates adaptive and innate immune signals
Kevin L. Otipoby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Ryan M. Young et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
Idit Sagiv-Barfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing
I. Vater et al.
LEUKEMIA (2015)
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
Sasha Bernatsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization
Monika Avbelj et al.
BLOOD (2014)
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
David W. Scott et al.
BLOOD (2014)
Evaluating Cell-of-Origin Subtype Methods for Predicting Diffuse Large B-Cell Lymphoma Survival: A Meta-Analysis of Gene Expression Profiling and Immunohistochemistry Algorithms
Jay A. Read et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2014)
Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
Ulla Randen et al.
HAEMATOLOGICA (2014)
Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance
James Q. Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma
Rami Rahal et al.
NATURE MEDICINE (2014)
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Jennifer A. Woyach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A. Mathews Griner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
Michele Ceribelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity
Zahra Sabouri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma
Scott A. Ezell et al.
ONCOTARGET (2014)
Mutational analysis of primary central nervous system lymphoma
Aurelie Bruno et al.
ONCOTARGET (2014)
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
Panagiotis Baliakas et al.
LANCET HAEMATOLOGY (2014)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
SYK Inhibition Modulates Distinct PI3K/AKT-Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas
Linfeng Chen et al.
CANCER CELL (2013)
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
Marieta Caganova et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Molecular Basis of 9G4 B Cell Autoreactivity in Human Systemic Lupus Erythematosus
Christopher Richardson et al.
JOURNAL OF IMMUNOLOGY (2013)
Structural Architecture of the CARMA1/Bcl10/MALT1 Signalosome: Nucleation-Induced Filamentous Assembly
Qi Qiao et al.
MOLECULAR CELL (2013)
Cis and Trans Regulatory Mechanisms Control AP2-Mediated B Cell Receptor Endocytosis via Select Tyrosine-Based Motifs
Kathleen Busman-Sahay et al.
PLOS ONE (2013)
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
Matthias Pfeifer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular Characterization of Immunoglobulin Gene Rearrangements in Diffuse Large B-Cell Lymphoma Antigen-Driven Origin and IGHV4-34 as a Particular Subgroup of the Non-GCB Subtype
Elena Sebastian et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Pathogenesis of Human B Cell Lymphomas
Arthur L. Shaffer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Germinal Centers
Gabriel D. Victora et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances
Lomon So et al.
BIOCHEMICAL JOURNAL (2012)
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
Sabine Ponader et al.
BLOOD (2012)
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
Andreas Agathangelidis et al.
BLOOD (2012)
MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
Lorena Fontan et al.
CANCER CELL (2012)
Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
Sandrine Sander et al.
CANCER CELL (2012)
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yibin Yang et al.
CANCER CELL (2012)
Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
Daniel Nagel et al.
CANCER CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Marcus Duehren-von Minden et al.
NATURE (2012)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz et al.
NATURE (2012)
The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
David Dominguez-Sola et al.
NATURE IMMUNOLOGY (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma
Manuel Montesinos-Rongen et al.
ACTA NEUROPATHOLOGICA (2011)
Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities
Fabrizio Marcucci et al.
BLOOD (2011)
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
Anastasia Hadzidimitriou et al.
BLOOD (2011)
SYK inhibition and response prediction in diffuse large B-cell lymphoma
Shuhua Cheng et al.
BLOOD (2011)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas
Tara L. Naylor et al.
CANCER RESEARCH (2011)
Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response
Baidong Hou et al.
IMMUNITY (2011)
Anergic Responses Characterize a Large Fraction of Human Autoreactive Naive B Cells Expressing Low Levels of Surface IgM
Tam D. Quach et al.
JOURNAL OF IMMUNOLOGY (2011)
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
T. E. Witzig et al.
LEUKEMIA (2011)
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma
P. Ruminy et al.
LEUKEMIA (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Critical role of PI3K signaling for NF-κB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
Bernhard Kloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg et al.
BLOOD (2010)
The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling
Mirza Suljagic et al.
BLOOD (2010)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer et al.
BLOOD (2010)
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin
Charles C. Chu et al.
BLOOD (2010)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter
Gabriel D. Victora et al.
CELL (2010)
Intrinsic Properties of immunoglobulin IgG1 Isotype-Switched B Cell Receptors Promote Microclustering and the Initiation of Signaling
Wanli Liu et al.
IMMUNITY (2010)
Temsirolimus Has Activity in Non-Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
Sonali M. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins
Vania Coelho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Christopher J. Sneeringer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The PI3K Isoforms p110α and p110δ Are Essential for Pre-B Cell Receptor Signaling and B Cell Development
Faruk Ramadani et al.
SCIENCE SIGNALING (2010)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Developmental Toxicity Associated with Receptor Tyrosine Kinase Ret Inhibition in Reproductive Toxicity Testing
George R. Clemens et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2009)
Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
Ryan M. Young et al.
BLOOD (2009)
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
Lakshmi Srinivasan et al.
CELL (2009)
The Constant Region of the Membrane Immunoglobulin Mediates B Cell-Receptor Clustering and Signaling in Response to Membrane Antigens
Pavel Tolar et al.
IMMUNITY (2009)
Autoinhibition and adapter function of Syk
Yogesh Kulathu et al.
IMMUNOLOGICAL REVIEWS (2009)
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells
Uta Ferch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance
Andrew J. Gross et al.
JOURNAL OF IMMUNOLOGY (2009)
Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells
S. Gobessi et al.
LEUKEMIA (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Multiple layers of B cell memory with different effector functions
Ismail Dogan et al.
NATURE IMMUNOLOGY (2009)
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
Stephan Hailfinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation
Rosa Catera et al.
MOLECULAR MEDICINE (2008)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
Membrane recognition by phospholipid-binding domains
Mark A. Lemmon
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay
Ola Soderberg et al.
METHODS (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas
Yosef Refaeli et al.
PLOS BIOLOGY (2008)
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
Linfeng Chen et al.
BLOOD (2008)
Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase
Yuichi Aiba et al.
BLOOD (2008)
Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors
Keisuke Horikawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma
Georg Lenz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor
Catherine M. Radcliffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antigen receptor signalling:: a distinctive role for the p110δ isoform of Pl3K
Klaus Okkenhaug et al.
TRENDS IN IMMUNOLOGY (2007)
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations
Kostas Stamatopoulos et al.
BLOOD (2007)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markers
F. Jardin et al.
LEUKEMIA (2006)
Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation
Roger Sciammas et al.
IMMUNITY (2006)
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
Ulf Klein et al.
NATURE IMMUNOLOGY (2006)
A loss-of-function RNA interference screen for molecular targets in cancer
VN Ngo et al.
NATURE (2006)
Bruton's tyrosine kinase is required for TLR2 and TLR4-Induced TNF, but not IL-6, production
Nicole J. Horwood et al.
JOURNAL OF IMMUNOLOGY (2006)
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
L Pasqualucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Phosphorylation of the CARMA1 linker controls NF-κB activation
K Sommer et al.
IMMUNITY (2005)
Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus
A Cappione et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity
M Hervé et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: Current knowledge and future directions
W Pao et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Systematic review:: regression of lymphoproliferative disorders after treatment for hepatitis C infection
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes
AJ Cappione et al.
JOURNAL OF IMMUNOLOGY (2004)
B cell antigen receptor signaling 101
JM Dal Porto et al.
MOLECULAR IMMUNOLOGY (2004)
Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer
M Kraus et al.
CELL (2004)
Glucocorticoids and invasive fungal infections
MS Lionakis et al.
LANCET (2003)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development
K Saijo et al.
NATURE IMMUNOLOGY (2003)
Evolution of autoantibody responses via somatic hypermutation outside of germinal centers
J William et al.
SCIENCE (2002)
Activation of phospholipase Cγ2 by tyrosine phosphorylation
F Özdener et al.
MOLECULAR PHARMACOLOGY (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
EA Leadbetter et al.
NATURE (2002)
Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma
DL Zhu et al.
BLOOD (2002)
Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory
SW Martin et al.
NATURE IMMUNOLOGY (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis
ER Quinn et al.
BLOOD (2001)
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Four tyrosine residues in phospholipase C-γ2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling
D Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection
A Morgner et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
AS Baldwin
JOURNAL OF CLINICAL INVESTIGATION (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Tyrosine kinase SYK: essential functions for immunoreceptor signalling
M Turner et al.
IMMUNOLOGY TODAY (2000)
Share Paper
